Dr Michael K Kizziah, MD - Medicare Diagnostic Radiology in Rome, GA

Dr Michael K Kizziah, MD is a medicare enrolled "Radiology - Diagnostic Radiology" physician in Rome, Georgia. He went to Mercer University School Of Medicine and graduated in 2005 and has 19 years of diverse experience with area of expertise as Diagnostic Radiology. He is a member of the group practice South Georgia Radiology Associates Llc, Harbin Clinic Llc, Rome Imaging Associates, Rome Radiology Group Pa, Rome Radiology Group Pa and his current practice location is 255 W 5th St Sw, Suite 150, Rome, Georgia. You can reach out to his office (for appointments etc.) via phone at (706) 232-1545.

Dr Michael K Kizziah is licensed to practice in Georgia (license number 065694) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1124108923.

Contact Information

Dr Michael K Kizziah, MD
255 W 5th St Sw, Suite 150,
Rome, GA 30165-2817
(706) 232-1545
(706) 232-3819



Physician's Profile

Full NameDr Michael K Kizziah
GenderMale
SpecialityDiagnostic Radiology
Experience19 Years
Location255 W 5th St Sw, Rome, Georgia
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Michael K Kizziah attended and graduated from Mercer University School Of Medicine in 2005
  NPI Data:
  • NPI Number: 1124108923
  • Provider Enumeration Date: 10/16/2006
  • Last Update Date: 11/09/2016
  Medicare PECOS Information:
  • PECOS PAC ID: 5092849505
  • Enrollment ID: I20110624000417

Medical Identifiers

Medical identifiers for Dr Michael K Kizziah such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1124108923NPI-NPPES
003123794BMedicaidGA
279442MedicaidSC

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2085B0100XRadiology - Body Imaging 27944 (South Carolina)Secondary
2085R0202XRadiology - Diagnostic Radiology 065694 (Georgia)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Floyd Medical CenterRome, GAHospital
Redmond Regional Medical CenterRome, GAHospital
Union General HospitalBlairsville, GAHospital
Adventhealth GordonCalhoun, GAHospital
Meadows Regional Medical CenterVidalia, GAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
South Georgia Radiology Associates Llc004238923137
Harbin Clinic Llc0446154231264
Rome Imaging Associates88200891215
Rome Radiology Group Pa892109169521
Rome Radiology Group Pa892109169521

News Archive

Promising drug for Duchenne muscular dystrophy

Duchenne muscular dystrophy is a severely debilitating and lethal condition that affects 1 in 3,000. Females and males are affected, though females are rarely affected and are more often carriers. It is caused due to a defective gene that normally codes for the protein dystrophin, which helps provide a protective membrane around muscle fibers. Without this skin, muscle fibers become damaged and eventually die.

Alexza obtains $20 million flexible financing facility from Azimuth Opportunity

Alexza Pharmaceuticals, Inc. announced today that it has obtained a committed equity financing facility under which it may sell up to $20 million of its registered common stock to Azimuth Opportunity, L.P., over an approximately 24-month period.

Phase 2 study of VX-661 and ivacaftor shows significant improvements in lung function among CF patients

Vertex Pharmaceuticals Incorporated today announced data from a Phase 2 study of VX-661 and ivacaftor that showed statistically significant improvements in lung function among adults with cystic fibrosis (CF) who have two copies (homozygous) of the most common mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, known as F508del.

Fusion guided imaging increases diagnostic accuracy of prostate biopsy procedures

UK hospital evaluation cites ‘revolution' with 16% sensitivity uplift in true positive rates. Greater diagnostic accuracy in detecting significant prostate cancer has been reported following a 4-year clinical evaluation at Castle Hill Hospital, part of Hull University Teaching Hospitals NHS Trust, using the Aplio i700 ultrasound system with ‘Smart Fusion' application.

Culture plays role in deciding what makes a mate attractive, says researcher

People in most cultures view women with small feet as attractive. Like smooth skin or an hourglass figure, petite feet signal a potential mate's youth and fertility.

Read more Medical News

› Verified 4 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Michael K Kizziah allows following entities to bill medicare on his behalf.
Entity NameHarbin Clinic Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1679599088
PECOS PAC ID: 0446154231
Enrollment ID: O20031124000117

News Archive

Promising drug for Duchenne muscular dystrophy

Duchenne muscular dystrophy is a severely debilitating and lethal condition that affects 1 in 3,000. Females and males are affected, though females are rarely affected and are more often carriers. It is caused due to a defective gene that normally codes for the protein dystrophin, which helps provide a protective membrane around muscle fibers. Without this skin, muscle fibers become damaged and eventually die.

Alexza obtains $20 million flexible financing facility from Azimuth Opportunity

Alexza Pharmaceuticals, Inc. announced today that it has obtained a committed equity financing facility under which it may sell up to $20 million of its registered common stock to Azimuth Opportunity, L.P., over an approximately 24-month period.

Phase 2 study of VX-661 and ivacaftor shows significant improvements in lung function among CF patients

Vertex Pharmaceuticals Incorporated today announced data from a Phase 2 study of VX-661 and ivacaftor that showed statistically significant improvements in lung function among adults with cystic fibrosis (CF) who have two copies (homozygous) of the most common mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, known as F508del.

Fusion guided imaging increases diagnostic accuracy of prostate biopsy procedures

UK hospital evaluation cites ‘revolution' with 16% sensitivity uplift in true positive rates. Greater diagnostic accuracy in detecting significant prostate cancer has been reported following a 4-year clinical evaluation at Castle Hill Hospital, part of Hull University Teaching Hospitals NHS Trust, using the Aplio i700 ultrasound system with ‘Smart Fusion' application.

Culture plays role in deciding what makes a mate attractive, says researcher

People in most cultures view women with small feet as attractive. Like smooth skin or an hourglass figure, petite feet signal a potential mate's youth and fertility.

Read more Medical News

› Verified 4 days ago

Entity NameRome Radiology Group Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1952330615
PECOS PAC ID: 8921091695
Enrollment ID: O20040407000833

News Archive

Promising drug for Duchenne muscular dystrophy

Duchenne muscular dystrophy is a severely debilitating and lethal condition that affects 1 in 3,000. Females and males are affected, though females are rarely affected and are more often carriers. It is caused due to a defective gene that normally codes for the protein dystrophin, which helps provide a protective membrane around muscle fibers. Without this skin, muscle fibers become damaged and eventually die.

Alexza obtains $20 million flexible financing facility from Azimuth Opportunity

Alexza Pharmaceuticals, Inc. announced today that it has obtained a committed equity financing facility under which it may sell up to $20 million of its registered common stock to Azimuth Opportunity, L.P., over an approximately 24-month period.

Phase 2 study of VX-661 and ivacaftor shows significant improvements in lung function among CF patients

Vertex Pharmaceuticals Incorporated today announced data from a Phase 2 study of VX-661 and ivacaftor that showed statistically significant improvements in lung function among adults with cystic fibrosis (CF) who have two copies (homozygous) of the most common mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, known as F508del.

Fusion guided imaging increases diagnostic accuracy of prostate biopsy procedures

UK hospital evaluation cites ‘revolution' with 16% sensitivity uplift in true positive rates. Greater diagnostic accuracy in detecting significant prostate cancer has been reported following a 4-year clinical evaluation at Castle Hill Hospital, part of Hull University Teaching Hospitals NHS Trust, using the Aplio i700 ultrasound system with ‘Smart Fusion' application.

Culture plays role in deciding what makes a mate attractive, says researcher

People in most cultures view women with small feet as attractive. Like smooth skin or an hourglass figure, petite feet signal a potential mate's youth and fertility.

Read more Medical News

› Verified 4 days ago

Entity NameRome Imaging Associates
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1013923820
PECOS PAC ID: 8820089121
Enrollment ID: O20040524000830

News Archive

Promising drug for Duchenne muscular dystrophy

Duchenne muscular dystrophy is a severely debilitating and lethal condition that affects 1 in 3,000. Females and males are affected, though females are rarely affected and are more often carriers. It is caused due to a defective gene that normally codes for the protein dystrophin, which helps provide a protective membrane around muscle fibers. Without this skin, muscle fibers become damaged and eventually die.

Alexza obtains $20 million flexible financing facility from Azimuth Opportunity

Alexza Pharmaceuticals, Inc. announced today that it has obtained a committed equity financing facility under which it may sell up to $20 million of its registered common stock to Azimuth Opportunity, L.P., over an approximately 24-month period.

Phase 2 study of VX-661 and ivacaftor shows significant improvements in lung function among CF patients

Vertex Pharmaceuticals Incorporated today announced data from a Phase 2 study of VX-661 and ivacaftor that showed statistically significant improvements in lung function among adults with cystic fibrosis (CF) who have two copies (homozygous) of the most common mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, known as F508del.

Fusion guided imaging increases diagnostic accuracy of prostate biopsy procedures

UK hospital evaluation cites ‘revolution' with 16% sensitivity uplift in true positive rates. Greater diagnostic accuracy in detecting significant prostate cancer has been reported following a 4-year clinical evaluation at Castle Hill Hospital, part of Hull University Teaching Hospitals NHS Trust, using the Aplio i700 ultrasound system with ‘Smart Fusion' application.

Culture plays role in deciding what makes a mate attractive, says researcher

People in most cultures view women with small feet as attractive. Like smooth skin or an hourglass figure, petite feet signal a potential mate's youth and fertility.

Read more Medical News

› Verified 4 days ago

Entity NameSouth Georgia Radiology Associates Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1760669931
PECOS PAC ID: 0042389231
Enrollment ID: O20080514000110

News Archive

Promising drug for Duchenne muscular dystrophy

Duchenne muscular dystrophy is a severely debilitating and lethal condition that affects 1 in 3,000. Females and males are affected, though females are rarely affected and are more often carriers. It is caused due to a defective gene that normally codes for the protein dystrophin, which helps provide a protective membrane around muscle fibers. Without this skin, muscle fibers become damaged and eventually die.

Alexza obtains $20 million flexible financing facility from Azimuth Opportunity

Alexza Pharmaceuticals, Inc. announced today that it has obtained a committed equity financing facility under which it may sell up to $20 million of its registered common stock to Azimuth Opportunity, L.P., over an approximately 24-month period.

Phase 2 study of VX-661 and ivacaftor shows significant improvements in lung function among CF patients

Vertex Pharmaceuticals Incorporated today announced data from a Phase 2 study of VX-661 and ivacaftor that showed statistically significant improvements in lung function among adults with cystic fibrosis (CF) who have two copies (homozygous) of the most common mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, known as F508del.

Fusion guided imaging increases diagnostic accuracy of prostate biopsy procedures

UK hospital evaluation cites ‘revolution' with 16% sensitivity uplift in true positive rates. Greater diagnostic accuracy in detecting significant prostate cancer has been reported following a 4-year clinical evaluation at Castle Hill Hospital, part of Hull University Teaching Hospitals NHS Trust, using the Aplio i700 ultrasound system with ‘Smart Fusion' application.

Culture plays role in deciding what makes a mate attractive, says researcher

People in most cultures view women with small feet as attractive. Like smooth skin or an hourglass figure, petite feet signal a potential mate's youth and fertility.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Michael K Kizziah is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Michael K Kizziah, MD
Po Box 369,
Rome, GA 30162-0369

Ph: (706) 291-2661
Dr Michael K Kizziah, MD
255 W 5th St Sw, Suite 150,
Rome, GA 30165-2817

Ph: (706) 232-1545

News Archive

Promising drug for Duchenne muscular dystrophy

Duchenne muscular dystrophy is a severely debilitating and lethal condition that affects 1 in 3,000. Females and males are affected, though females are rarely affected and are more often carriers. It is caused due to a defective gene that normally codes for the protein dystrophin, which helps provide a protective membrane around muscle fibers. Without this skin, muscle fibers become damaged and eventually die.

Alexza obtains $20 million flexible financing facility from Azimuth Opportunity

Alexza Pharmaceuticals, Inc. announced today that it has obtained a committed equity financing facility under which it may sell up to $20 million of its registered common stock to Azimuth Opportunity, L.P., over an approximately 24-month period.

Phase 2 study of VX-661 and ivacaftor shows significant improvements in lung function among CF patients

Vertex Pharmaceuticals Incorporated today announced data from a Phase 2 study of VX-661 and ivacaftor that showed statistically significant improvements in lung function among adults with cystic fibrosis (CF) who have two copies (homozygous) of the most common mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, known as F508del.

Fusion guided imaging increases diagnostic accuracy of prostate biopsy procedures

UK hospital evaluation cites ‘revolution' with 16% sensitivity uplift in true positive rates. Greater diagnostic accuracy in detecting significant prostate cancer has been reported following a 4-year clinical evaluation at Castle Hill Hospital, part of Hull University Teaching Hospitals NHS Trust, using the Aplio i700 ultrasound system with ‘Smart Fusion' application.

Culture plays role in deciding what makes a mate attractive, says researcher

People in most cultures view women with small feet as attractive. Like smooth skin or an hourglass figure, petite feet signal a potential mate's youth and fertility.

Read more News

› Verified 4 days ago


Radiology Doctors in Rome, GA

Dr. Steven W Pruett, M.D.
Radiology
Medicare: Not Enrolled in Medicare
Practice Location: 1104 Martha Berry Blvd Ne, Rome, GA 30165
Phone: 706-291-2077    Fax: 706-235-4177
Matthew Peter Mumber, MD
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 255 W 5th St Sw, Rome, GA 30165
Phone: 706-234-1400    Fax: 706-232-5018
Dr. Chad Harple, M.D.
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 901 N Broad St Ne, Rome, GA 30161
Phone: 706-291-2661    
William P Harbin Ii,
Radiology
Medicare: Medicare Enrolled
Practice Location: 901 N Broad St Ne, Suite 220, Rome, GA 30161
Phone: 706-291-2077    
J. Daniel Hanks Jr.,
Radiology
Medicare: Not Enrolled in Medicare
Practice Location: 1104 Martha Berry Blvd Ne, Rome, GA 30165
Phone: 706-291-2077    
John Christopher Abdou, MD
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 255 W 5th St Sw, Rome, GA 30165
Phone: 706-234-1400    Fax: 706-232-5018

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.